Molecular and biological factors in the prognosis of non-small cell lung cancer

For patients with non-small cell lung cancer the tumour/node/metastasis (TNM) staging system and other conventional prognostic factors fail to predict the outcome of treatment and survival accurately. New prognostic factors are urgently needed to improve understanding of the biological behaviour of...

Full description

Saved in:

Bibliographic Details
Published in:	The European respiratory journal Vol. 8; no. 8; pp. 1389 - 1397
Main Authors:	Kanters, SD, Lammers, JW, Voest, EE
Format:	Journal Article
Language:	English
Published:	Leeds Eur Respiratory Soc 01-08-1995 Maney
Subjects:	Biological and medical sciences Biomarkers, Tumor - analysis Carcinoma, Non-Small-Cell Lung - chemistry Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology DNA, Neoplasm - analysis Genes, Tumor Suppressor Humans Lung Neoplasms - chemistry Lung Neoplasms - diagnosis Lung Neoplasms - genetics Lung Neoplasms - pathology Medical sciences Oncogenes Pneumology Prognosis Tumors of the respiratory system and mediastinum Human Angiogenesis Prognosis Respiratory disease Lung Malignant tumor Onc gene
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	For patients with non-small cell lung cancer the tumour/node/metastasis (TNM) staging system and other conventional prognostic factors fail to predict the outcome of treatment and survival accurately. New prognostic factors are urgently needed to improve understanding of the biological behaviour of the different subtypes of non-small cell lung cancer and to recognize patients with a good or poor prognosis. This review will focus on molecular and biological factors published in the English language literature between 1988 and 1994. To be included in this survey, the predictive value of a specific prognostic factor had to be confirmed by multivariate analysis in at least two different studies. Blood group antigen expression, ras oncogenes, microvessel density, and factors reflecting the proliferative state of the tumour may be important determinants of outcome of treatment. The search for new determinants of prognosis has provided insight in the complex tumour biology of non-small cell lung cancer and indicated possible targets for tumour therapy. Several promising prognostic factors have now been recognized. To validate these factors, prospective studies of a large patient population are needed. This ultimately serves the recognition of subsets of patients who may benefit from adjuvant therapy.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	0903-1936 1399-3003
DOI:	10.1183/09031936.95.08081389